%0 Journal Article
%A Torres, Eulalia Baselga
%A Wittel, Jose Bernabeu
%A van Esso Arbolave, Diego L.
%A Febrer Bosch, Maria Isabel
%A Sanz, Angel Carrasco
%A Laguna, Raul de Lucas
%A Losada, Jesus del Pozo
%A Martin, Angela Hernandez
%A Montanes, Lorenzo Jimenez
%A Lopez Gutierrez, Juan Carlos
%A Martin-Santiago, Ana
%A Bellon, Pedro Redondo
%A Caceres, Juan Ruiz-Canela
%A Fernandez, Antonio Torrelo
%A Casano, Angel Vera
%A Vicente Villa, Maria Asuncion
%T Spanish consensus on infantile haemangioma
%D 2016
%@ 1695-4033
%U http://hdl.handle.net/10668/18678
%X Introduction: Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences.Methods: The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement.Results: This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient.Conclusions: The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients. (C) 2015 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U. All rights reserved.
%K Haemangioma/diagnosis
%K Haemangioma/drug therapy
%K Haemangioma/complications
%K Haemangioma/classification
%K Propranolol
%K Infant
%K Algorithms
%K Clinical characteristics
%K Phace syndrome
%K Risk-factors
%K Propranolol
%K Management
%K Complications
%K Infancy
%K Timolol
%K Cohort
%~